The future of the global venous diseases treatment market looks promising with opportunities in the sclerotherapy, radiofrequency ablation therapy, laser treatment, ambulatory phlebectomy, vein ligation & stripping, angioplasty or stenting, surgeries, compression therapy, venoactive medication, and vena cava filter markets. The global venous diseases treatment market is expected to reach an estimated $9.1 billion by 2030 with a CAGR of 6.5% from 2024 to 2030. The major drivers for this market are increasing incidences of venous diseases, growing awareness towards venous disorders, and rising healthcare expenditure.
Some of the key questions
answered in this exclusive report are:
Q.1. What are some of
the most promising, high-growth opportunities for the venous diseases treatment
market by product type (sclerotherapy injection, ablation devices, venous
closure products, venous stents, medication, and others), disease type (deep
vein thrombosis, chronic venous insufficiency, pulmonary embolism, superficial
thrombophlebitis, varicose veins, and others), treatment type (sclerotherapy,
radiofrequency ablation therapy, laser treatment, ambulatory phlebectomy, vein
ligation & stripping, angioplasty or stenting, surgeries, compression
therapy, and others), end use (hospitals, clinics, ambulatory surgical centers,
and others), and region (North America, Europe, Asia Pacific, and the Rest of
the World)?
Q.2. Which segments will
grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and
why?
Q.4. What are the key
factors affecting market dynamics? What are the key challenges and business
risks in this market?
Q.5. What are the
business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market
and the reasons behind them?
Q.7. What are some of
the changing demands of customers in the market?
Q.8. What are the new
developments in the market? Which companies are leading these developments?
Q.9. Who are the major
players in this market? What strategic initiatives are key players pursuing for
business growth?
Q.10. What are some of
the competing products in this market and how big of a threat do they pose for
loss of market share by material or product substitution?
Q.11. What M&A
activity has occurred in the last 5 years and what has its impact been on the
industry?
Market Segmentation:
In this market, deep
vein thrombosis, chronic venous insufficiency, pulmonary embolism, superficial
thrombophlebitis, and varicose veins are the major segments of venous diseases
treatment market by disease type. Lucintel forecasts that varicose veins will
remain the largest segment due to the increasing cases of varicose veins and
minimally invasive procedures to treat varicose veins.
Within this market,
laser treatment is expected to witness highest growth over the forecast period
due to rising demand for minimal invasive procedure with less cure time and
om-going technological development to treat venous diseases.
North America will
remain the largest region due to growing number of varicose veins diseases
among the US population, significantly growing aging population, and
technological advancement of diagnosis and treatment in the region.
Abbott, Imricor,
Medtronic, Stryker, Koninklijke Philips, Baylis Medical, Theraclion, Sonablate,
Boston Scientific, and Olympus are the major suppliers in the venous diseases
treatment market.
About
Lucintel
Lucintel, the premier global
management consulting and market research firm, creates winning strategies for
growth. It offers market assessments, competitive analysis, opportunity
analysis, growth
consulting, M&A, and due diligence services to executives and
key decision-makers in a variety of industries.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. 972.636.5056
Related Reports
1. Pharmaceutical Contract Manufacturing Market
3. Stent Market
5. 3D
Printing Medical Device Market
8. Medical Lifting Sling
Market
10. Stretcher Market
No comments:
Post a Comment